Faruqi and Faruqui, LLP Logo
Share this page

Genocea Biosciences Inc. (GNCA)



Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Genocea Biosciences, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Genocea Biosciences, Inc. (“Genocea” or the “Company”) (NASDAQ: GNCA) of the January 2, 2018 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

If you invested in Genocea securities between May 5, 2017 and September 25, 2017 and would like to discuss your legal rights, please fill out the form below. There is no cost or obligation to you.

You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com. 

The lawsuit has been filed in the U.S. District Court for the District of Massachusetts on behalf of all those who purchased Genocea securities between May 5, 2017 and September 25, 2017 (the “Class Period”).  The case, Emerson v. Genocea Biosciences, Inc., No. 1:17-cv-12137 was filed on October 31, 2017.

The lawsuit focuses on whether the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (i) the Company's finances were insufficient to support Phase 3 trials of the Company’s lead product candidate GEN-003; (ii) accordingly, Genocea had overstated the prospects for GEN-003; and (iii) as a result of the foregoing, Genocea's public statements were materially false and misleading at all relevant times.

Specifically, on September 25, 2017, after market close, Genocea disclosed that it was halting spending and activities on GEN-003 and exploring strategic alternatives for the drug. Additionally, the Company announced that it was cutting 40% of its workforce.

On this news, Genocea’s share price fell from $5.33 per share on September 25, 2017 to a closing price of $1.25 on September 26, 2017—a $4.08 or a 76.55% drop.

Contact Us

To contact Faruqi & Faruqi, LLP please call (877) 247-4292 or (212) 983-9330, or please
fill out the form below and a Firm representative will contact you.

  • Case:
    Genocea Biosciences Inc. (GNCA)

* The submission of this form does not create an attorney-client relationship.

Contact Counsel

Richard W. Gonnello
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330


Case Details


  • 11/01/2017

Send Information

If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.